Proteomics International Laboratories Ltd (ASX:PIQ)

Australia flag Australia · Delayed Price · Currency is AUD
0.3250
+0.0350 (12.07%)
Jun 30, 2025, 4:10 PM AEST
-63.28%
Market Cap 53.14M
Revenue (ttm) 3.50M
Net Income (ttm) -7.11M
Shares Out 163.52M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 291,301
Average Volume 357,089
Open 0.2950
Previous Close 0.2900
Day's Range 0.2950 - 0.3400
52-Week Range 0.2850 - 1.1200
Beta 0.14
RSI 25.31
Earnings Date Aug 21, 2025

About ASX:PIQ

Proteomics International Laboratories Ltd operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia. It provides PromarkerD, a protein-based diagnostic blood test to predict diabetic kidney disease (DKD). The company’s products under development include PromarkerEndo, which has completed clinical validation phase for endometriosis diagnosis; PromarkerEso, that has completed clinical validation trials for esophageal cancer diagnosis; and OxiDx ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol PIQ
Full Company Profile

Financial Performance

In 2024, ASX:PIQ's revenue was 3.28 million, an increase of 2.99% compared to the previous year's 3.18 million. Losses were -6.38 million, 3.23% more than in 2023.

Financial Statements

News

There is no news available yet.